Mot-clés
ICP-MS (3)
- Radium (3)
- Uranium (3)
- Bisphosphonate (2)
- Ion-imprinted polymer (2)
- Solid phase extraction (2)
- Uranium mines (2)
- 233 U (1)
- 234U/238U activity ratio (1)
- 236 U (1)
- Absorption cutanée (1)
- Alpha-emitter (1)
- Anions (1)
- Argent (1)
- Barium (1)
- Beauce aquifer (1)
- Bisphosphonate internal contamination radionuclide nanotechnologies controlled drug delivery repurposing drug (1)
- Bone marrow (1)
- Bone marrow Patient dosimetry (1)
- COVID-19 (1)
- Calixarène (1)
- Calu-3 (1)
- Chemical extraction (1)
- Chitosan (1)
- Chronic toxicity (1)
- Clay rock (1)
- Cleansing products (1)
- Cobalt 60 (1)
- Controlled drug delivery (1)
- DOTA (1)
- Decontamination (1)
- Dermatite (1)
- Diffusive Gradients in Thin-films DGT (1)
- Diffusive equilibrium in thin-films (1)
- Dioxyde de titane (1)
- Dose heterogeneity (1)
- Dose heterogeneity Radiopharmaceutical therapy Alpha-emitter Normal tissue (1)
- Décontamination (1)
- Environmental radiochemistry (1)
- Essonne river (1)
- Europe (1)
- Ex vivo (1)
- Exposition professionnelle (1)
- Fick's law (1)
- Field application (1)
- Gestion risques (1)
- Heat transfer (1)
- Hygiène peau (1)
- Hygiène professionnelle (1)
- Immunohistochemistry (1)